Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 28 Apr 2017 Results (n=13) presented at the 69th Annual Meeting of the American Academy of Neurology.
- 31 Jul 2013 Planned End Date changed from 1 Jun 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 04 Jul 2012 New trial record